SEO Title
DOT To Add Fentanyl to Mandatory Drug Test List
Subtitle
Fentanyl use on the rise
Teaser Text
The DOT is harmonizing its regulations with HHS with the addition of fentanyl to the mandatory drug testing list as use of the drug continues to grow.
Content Body

The U.S. Department of Transportation (DOT) is proposing to add fentanyl/norfentanyl to the list of drugs screened for in the mandatory workplace drug and alcohol testing program. Published in the Federal Register, the notice of proposed rulemaking (NPRM) said the additions of fentanyl, a synthetic opioid, and norfentanyl, a metabolite of fentanyl, would harmonize the list with that of the Department of Health and Human Services’ (HHS) mandatory guidelines for federal workplace drug testing programs.

In the NPRM, DOT noted that it has discretion over certain aspects of the mandatory testing program, but HHS establishes the mandatory list of drugs. The department added that the move is in the interest of transportation safety, “given compelling information regarding the number of overdose deaths in the United States involving fentanyl.”

Noted in the proposal were HHS findings that fentanyl accounts for a large proportion of overdose deaths and is increasingly used as a standalone substance of abuse, not in conjunction with heroin and other substances as was common in the past.

While drug findings involving covered aviation workers are not common—in 2023, the FAA reported 0.881% positive results from random tests—it is typically more commonly discovered in Part 91 pilots, and an NTSB study reported increasing incidents of performance-impairing drugs found in accident pilots.

The study, “Safety Research Report: 2013–2017 Update to Drug Use Trends in Aviation,” found 28% of 952 pilots killed in crashes during that period tested positive for at least one “potential impairing” drug. Almost all—97%—involved general aviation pilots. That compared with 23% for pilots assessed between 1990 and 2012.

More recently, in a June 29 fatal crash of a Cessna 441 outside Warren, Ohio, a pilot who was listed as a passenger but situated in the right seat tested positive for fentanyl, according to multiple reports. That pilot had flown for both airlines and corporations. All six aboard the aircraft died. The investigation is still ongoing.

Comments on the proposal are due October 17.

Expert Opinion
False
Ads Enabled
True
Used in Print
False
Writer(s) - Credited
Kerry Lynch
Newsletter Headline
DOT To Add Fentanyl to Mandatory Drug Test List
Newsletter Body

The U.S. Department of Transportation (DOT) is proposing to add fentanyl/norfentanyl to the list of drugs screened for in the mandatory workplace drug and alcohol testing program. Published in the Federal Register, the notice of proposed rulemaking (NPRM) said the additions of fentanyl, a synthetic opioid, and norfentanyl, a metabolite of fentanyl, would harmonize the list with that of the Department of Health and Human Services’ mandatory guidelines for federal workplace drug testing programs.

In the NPRM, the DOT added that the move is in the interest of transportation safety, “given compelling information regarding the number of overdose deaths in the United States involving fentanyl.”

While drug findings involving covered aviation workers are not common—in 2023, the FAA reported 0.881% positive results from random tests—it is typically more commonly discovered in Part 91 pilots, and an NTSB study reported increasing incidents of performance-impairing drugs found in accident pilots.

More recently, in a June 29 fatal crash of a Cessna 441 outside Warren, Ohio, a pilot who was listed as a passenger but situated in the right seat tested positive for fentanyl, according to multiple reports. All six aboard the aircraft died. The investigation is still ongoing.

Comments on the proposal are due October 17.

Solutions in Business Aviation
0
AIN Publication Date
----------------------------